By Research Area
Hot products 
-
Mouse Anti-CDK7 Recombinant Antibody (CBYY-C1783) (CBMAB-C3221-YY)
-
Mouse Anti-AQP2 Recombinant Antibody (E-2) (CBMAB-A3358-YC)
-
Mouse Anti-AGK Recombinant Antibody (V2-258056) (CBMAB-M0989-FY)
-
Mouse Anti-14-3-3 Pan Recombinant Antibody (V2-9272) (CBMAB-1181-LY)
-
Mouse Anti-ALPL Antibody (B4-78) (CBMAB-1009CQ)
-
Mouse Anti-CTCF Recombinant Antibody (CBFYC-2371) (CBMAB-C2443-FY)
-
Mouse Anti-NSUN6 Recombinant Antibody (D-5) (CBMAB-N3674-WJ)
-
Mouse Anti-ARG1 Recombinant Antibody (CBYCL-103) (CBMAB-L0004-YC)
-
Mouse Anti-EMP3 Recombinant Antibody (CBFYE-0100) (CBMAB-E0207-FY)
-
Mouse Anti-AKR1B1 Antibody (V2-2449) (CBMAB-1001CQ)
-
Mouse Anti-CD46 Recombinant Antibody (CBFYC-0076) (CBMAB-C0085-FY)
-
Rat Anti-CD34 Recombinant Antibody (MEC 14.7) (CBMAB-C10196-LY)
-
Rabbit Anti-DLK1 Recombinant Antibody (9D8) (CBMAB-D1061-YC)
-
Mouse Anti-CCL18 Recombinant Antibody (64507) (CBMAB-C7910-LY)
-
Mouse Anti-GFAP Recombinant Antibody (5) (CBMAB-G0346-LY)
-
Mouse Anti-AKT1 Recombinant Antibody (V2-180546) (CBMAB-A2070-YC)
-
Mouse Anti-APP Recombinant Antibody (DE2B4) (CBMAB-1122-CN)
-
Mouse Anti-ADGRE5 Recombinant Antibody (V2-360335) (CBMAB-C2088-CQ)
-
Mouse Anti-FN1 Monoclonal Antibody (71) (CBMAB-1241CQ)
-
Mouse Anti-C1QC Recombinant Antibody (CBFYC-0600) (CBMAB-C0654-FY)
Glycobiology Research
Glycobiology investigates the structure, biosynthesis, and biological roles of glycans—complex carbohydrate chains covalently attached to proteins (glycoproteins) and lipids (glycolipids). These glycoconjugates are ubiquitous across all domains of life, forming a dynamic "sugar code" that regulates cellular communication, protein folding, immune recognition, and pathogen-host interactions. Unlike linear genetic information, glycans exhibit branching diversity, enabling them to serve as versatile molecular signals in health and disease.
Glycans modulate critical biological processes through precise interactions with lectins, antibodies, and enzymes. For instance, cell-surface glycoproteins govern leukocyte trafficking by binding selectins during inflammation, while glycosaminoglycans orchestrate extracellular matrix remodeling. Aberrant glycosylation—a hallmark of pathological states—is implicated in cancer metastasis, autoimmune disorders, and viral entry mechanisms. High-mannose glycans, for example, facilitate viral immune evasion by masking antigenic epitopes on viral envelopes.
Dysregulated glycan synthesis drives disease progression through altered cell adhesion, signaling, and immune surveillance. Tumor-associated carbohydrate antigens (TACAs), such as sialyl Lewis X, correlate with metastatic potential by promoting circulating tumor cell adhesion to vascular endothelium. Similarly, autoimmune conditions like lupus exhibit autoantibodies targeting glycosylated self-antigens. Advanced glycation end-products (AGEs), formed via non-enzymatic glycosylation, further contribute to diabetic complications and neurodegenerative pathologies.
Creative Biolabs provides rigorously validated antibodies targeting glycan epitopes, glycosyltransferases, and lectins, essential for elucidating glycan-mediated pathways. Our products are optimized for applications including flow cytometry, immunohistochemistry, and glycan array analysis, ensuring high specificity and batch-to-batch consistency. Leverage our expertise to dissect the sugar code's role in your disease models or therapeutic discovery pipelines.
Loading...
Compare
